Business Description
Akili Inc
NAICS : 923120
SIC : 7372
Description
Akili Inc is a digital medicine company pioneering the development of cognitive treatments through game-changing technologies.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 6.82 | |||||
| Equity-to-Asset | 0.77 | |||||
| Debt-to-Equity | 0.18 | |||||
| Debt-to-EBITDA | 1.3 | |||||
| Piotroski F-Score | N/A/9 | |||||
| Altman Z-Score | 0.41 | |||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -65 | |||||
| 3-Year EBITDA Growth Rate | 7.5 | |||||
| 3-Year EPS without NRI Growth Rate | -34.2 | |||||
| 3-Year FCF Growth Rate | -94 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 21.66 | |||||
| 9-Day RSI | 29.05 | |||||
| 14-Day RSI | 36.07 | |||||
| 6-1 Month Momentum % | -54.08 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 10.37 | |||||
| Quick Ratio | 10.37 | |||||
| Cash Ratio | 10.01 | |||||
| Days Sales Outstanding | 41.54 | |||||
| Days Payable | 3391.06 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -0.1 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | -34.24 | |||||
| Operating Margin % | -26829.57 | |||||
| Net Margin % | 5419.46 | |||||
| ROE % | 26.66 | |||||
| ROA % | 12.5 | |||||
| ROIC % | -1222.85 | |||||
| ROC (Joel Greenblatt) % | 500 | |||||
| ROCE % | 15.25 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 5.57 | |||||
| PE Ratio without NRI | 5.57 | |||||
| PS Ratio | 426.67 | |||||
| PB Ratio | 0.9 | |||||
| Price-to-Tangible-Book | 0.9 | |||||
| EV-to-EBIT | -1.06 | |||||
| EV-to-Forward-EBIT | -0.08 | |||||
| EV-to-EBITDA | -1.06 | |||||
| EV-to-Revenue | -63.04 | |||||
| EV-to-Forward-Revenue | 2.46 | |||||
| EV-to-FCF | 0.19 | |||||
| Price-to-Graham-Number | 0.47 | |||||
| Price-to-Net-Current-Asset-Value | 0.93 | |||||
| Price-to-Net-Cash | 0.98 | |||||
| Earnings Yield (Greenblatt) % | -94.34 |
How Akili Inc (AKLI) Makes Its Money
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:AKLI
Peter Lynch Chart
Performance
Dividend
Log
Annualized Return %
Total Annual Return %
Executives
Details
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.257 | ||
| EPS (TTM) ($) | 0.23 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 36.07 | ||
| 14-Day ATR ($) | 0.180718 | ||
| 20-Day SMA ($) | 1.6115 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range ($) | 0.85505 - 37.5807 | ||
| Shares Outstanding (Mil) | 78.1 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Akili Inc Filings
| Document | Form | Filing Date | ||
|---|---|---|---|---|
| No Filing Data | ||||
Akili Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Akili Inc Frequently Asked Questions
What is Akili Inc(AKLI)'s stock price today?
The current price of AKLI is $1.28. The 52 week high of AKLI is $37.58 and 52 week low is $0.86.
When is next earnings date of Akili Inc(AKLI)?
The next earnings date of Akili Inc(AKLI) is 2023-06-30 Est..
Does Akili Inc(AKLI) pay dividends? If so, how much?
Akili Inc(AKLI) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
